GET THE APP

About

Feb 23-24, 2022    Singapore city, Singapore

1st International Conference on

Clinical Oncology

1st International Conference on Clinical Oncology welcomes all the attendees, speakers, sponsor’s and other research expertise from all over the world which is going to be held during February 23-24, 2022 in Singapore. We are honoured to invite you all to exchange and share your views and experience on the Clinical Oncology Conference.

Clinical will provide a wonderful platform for you to refresh your knowledge base and explore the innovations in Oncology. The conference will strive to offer plenty of networking opportunities, providing you with the opportunity to meet and interact with the leading scientists and researchers, friends and colleagues as well as sponsors and exhibitors. The theme of the conference “Latest Challenges to explore advancements in Cancer” will underpin the need for collaboration and cooperation of individuals from a wide range of professional backgrounds.

Sessions/Tracks

Track 1: Cancer & Oncology

Oncology is the study of cancer. An oncology doctor who treats cancer and provides medical care for a person diagnosed with cancer. The three major field of oncology have: medical, surgical, and radiation. The types of cancer are carcinoma, sarcoma, melanoma, lymphoma, and leukaemia. The most commonly diagnosed cancers - originate in the skin, lungs, breasts, pancreas, and other organs and glands.

Related Keywords: Oncogenes Forum | Cancer Summit | Neoplsatic Conference | Ovarian Cancer Congress | Tumors Symposium

Track 2: Cancer Research and Therapy

The ultimate goal of cancer research is to save lives by developing safe and productive methods to prevent, detect, diagnose and treat the people suffering from cancer. Depending on the type of cancer in patients the treatment varies like surgery, chemotherapy or radiotherapy. For some types of cancer targeted therapies are also available.

Related Keywords: Oncogenes Forum | Cancer Summit | Neoplsatic Conference | Ovarian Cancer Congress | Tumors Symposium

Track 3: Gynecologic Cancer

Gynecologic cancer is a cancer that starts in a female’s reproductive organs. Five important types of cancer affect a female's reproductive organs are listed bin the sub-tracks. Fallopian tube cancer is the 6th type of gynecologic cancer which is rare comparing to the listed top 5 gynecologic cancers. The signs and symptoms for each type of the gynecologic cancer is different and the risk is based on age factor. The early treatment of gynecologic cancer is considered to be more effective.

Related Keywords: Oncogenes Forum | Cancer Summit | Neoplsatic Conference | Ovarian Cancer Congress | Tumors Symposium

Track 4: Pulmonology Cancer

Our cancer doctors establish tumours, blockages or internal haemorrhage and use advanced carcinoma treatments to cut back or eliminate symptoms. Treatment-related aspect effects: Some carcinoma treatments, like therapy, might be cause scarring within the lungs. Whereas we tend to attempt to scale back these facet effects, aggressive carcinoma treatment might cause ineluctable complications.

Related Keywords: Oncogenes Forum | Cancer Summit | Neoplsatic Conference | Ovarian Cancer Congress | Tumors Symposium

Track 5: Breast Cancer

The most common invasive cancer in women is Breast cancer. After lung cancer the most leading cancer to cause deaths is Breast cancer. Initially the tumour cells are formed in the glands of breast and then get developed in the tissues. There are even types in breast cancer that are listed below in sub tracks. Lumpectomy, Mastectomy, Sentinel node biopsy, Axillary lymph node dissection and contralateral prophylactic mastectomy are the different types of surgeries performed to treat the breast cancers. Other types of treatments also were used to treat the breast cancer.

Related Keywords: Oncogenes Forum | Cancer Summit | Neoplsatic Conference | Ovarian Cancer Congress | Tumors Symposium

Track 6: Skin Cancer

The out-of-control growth of cancer cells in the epidermis is known as the skin cancer.  In the outermost skin layer, skin cancer is caused by unrepaired DNA damage that triggers mutations. Thus, the skin cells are multiplied rapidly and form malignant tumours due to these mutations. At early stages, skin cancer can be treated by Mohs surgery. Untreated skin cancers may become more dangerous since it may be spread.

Related Keywords: Oncogenes Forum | Cancer Summit | Neoplsatic Conference | Ovarian Cancer Congress | Tumors Symposium

Track 7: Blood & Bone Cancer

The most frequently occurring cancer that causes bone tumours is called multiple myeloma which is cancer of the blood. Leukaemia is another cancer that starts in the bone marrow. The food that we eat can also cause blood cancer. Blood is produced from bone marrow, thus blood cancer origin from bone marrow by the abnormal growth of cells in the blood forming cells.

Related Keywords: Oncogenes Forum | Cancer Summit | Neoplsatic Conference | Ovarian Cancer Congress | Tumors Symposium

Market Report of Clinical Oncology

The global cancer / tumor profiling market valued at $13.30 billion in 2012. By the end of 2013, the market was estimated at $14.99 billion and is expected to reach about $35 billion in 2018, with compound annual growth rate of 18.50%. 2018. Global spending on oncology reached $91 billion in 2013 and grew by 5% annually, reaching $100 billion in 2015. Key players in the cancer and tumor market are Boreal Genomics Inc. (United States), Caris Life Sciences. (United States), Genomic Health Inc. (United States), Illumina Inc. (United States), Life Technologies Corporation (United States), Neo Genomics Laboratories (United States), Oxford Gene Technology Ltd. (United Kingdom), Precision Therapeutics Inc. (United States), bioTheranostics (United States), Proteome Sciences PLC (United Kingdom), Agendia (Netherlands), Nanostring Technologies (United States), Rational Therapeutics (United States), United States), Oncopath Laboratories (United States) and Ribo Med Biotechnologies Inc. (WE.). The global cancer diagnostic market is expected to reach $13.1 billion in 2020, up from about $7.1 billion in 2015, with a CAGR of 12.9%.

The market is dominated by North America, followed by Europe, Asia and the rest of the world. The Asian cancer diagnostic market is expected to grow at its fastest pace from 2015 to 2020. According to the market, the global market for oncology drugs is expected to reach $111.9 billion by 2020. The patent expires in key anti-cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin are expected to drive growth in the cancer biosimilar market by 2020.

Past Conferences Report

Euro Oncology 2021 Report

We gratefully thank all our wonderful speakers, conference attendees, students, media partners, associations and exhibitors for making Euro Oncology 2021 conference the best ever!

International Conference on Oncology and Radiology, hosted by the Longdom Conference was held during July 26-27, 2021 in Singapore City, Singapore based on the theme “New Challenges and Explore the Prevention of Oncology

The conference was initiated with the honourable presence of the keynote forum. The list includes:

  1. Salah-Eddine Lamhamedi-Cherradi, University of Texas MD Anderson Cancer Center,  USA
  2. Mahmoud Saad Mohamed El-Khodary, Suez Canal University, Egypt
  3. Pechersky, Alexander, North-Western State Medical University, Russia
  4. Kais Razzouk, Nice Breast Institute, France
  5. Rania Harati, University of Sharjah, UAE

With the grand success of Euro Oncology 2021, Longdom Conferences is proud to announce the "International Conference on Clinical Oncology" to be held February 23-24, 2022 at Singapore city, Singapore.

For more details visit: https://www.longdom.com/oncology

Cancer 2020 Report

We gratefully thank all our wonderful speakers, conference attendees, students, media partners, associations and exhibitors for making Cancer 2020 conference the best ever!

New trends in Cancer Immunotherapy and Immunology, hosted by the Longdom Conference was held during October 19-20, 2020 Vancouver, Canada based on the theme “Novel Research for Cancer-Free World

The conference was initiated with the honourable presence of the keynote forum. The list includes:

  1. Bineta Keneme, Cheikh Anta Diop University, Dakar-Senegal
  2. Michail R Ponizovskiy, Vinitsa National Medical University, Ukraine
  3. Alireza Alaleh, University Hospital, Iran
  4. Diana Anderson, University of Bradford, England
  5. Jack C. Westman, University of Wisconsin, United States

With the grand success of Cancer 2020, Longdom Conferences  is proud to announce the "International Conference on Clinical Oncology" to be held February 23-24, 2022 at Singapore city, Singapore.

For more details visit: https://www.longdom.com/oncology

Oncology-Congress-2020 Report

We gratefully thank all our wonderful speakers, conference attendees, students, media partners, associations and exhibitors for making Oncology-Congress-2020 conference the best ever!

Oncology and Breast Cancer, hosted by the Longdom Conference was held during May 05, 2020 in Vienna, Austria based on the theme “Awareness is the Key to Eradicate Cancer

The conference was initiated with the honourable presence of the keynote forum. The list includes:

  1. Soo-Foon Moey, Universiti Teknologi Malaysia, Malaysia.
  2. Jehad Zweiri, University of Liverpool Medical School, Jordan
  3. Barrington Brevitt, University of the West Indies (UWI), West Indies
  4. Tarang Krishna, University of London, UK
  5. Pallavi Dhillon, Head of Clinical Operations and Drug safety, USA.

With the grand success of Oncology-Congress-2020, Longdom Conferences is proud to announce the "International Conference on Clinical Oncology" to be held February 23-24, 2022 at Singapore city, Singapore.

For more details visit: https://www.longdom.com/oncology

Neurooncology-2020 Report

We gratefully thank all our wonderful speakers, conference attendees, students, media partners, associations and exhibitors for making Neurooncology-2020 conference the best ever!

Oncology and Cancer Therapy, hosted by the Longdom Conference was held during November 23-24, 2020 in New York, USA based on the theme “Empowering the Modern Research Incline to Conquer Cancer

The conference was initiated with the honourable presence of the keynote forum. The list includes:

  1. El Hadji Seydou Mbaye, Louis Pasteur University of Strasbourg, France
  2. Michael Retsky, University of Colorado – Colorado, USA
  3. Naiyarat Prasongsook , Medical Oncology from Ramathibodi Hospital, Bangkok.
  4. Robens Saintil, Padre Billini Hospital and Clinical Oncology in Heriberto Pieter Oncology Institute, Dominican Republic.
  5. Morganna Vance, Melanoma Medical Affairs division at Novartis US

With the grand success of Neurooncology-2020, Longdom Conferences is proud to announce the "International Conference on Clinical Oncology" to be held February 23-24, 2022 at Singapore city, Singapore.

For more details visit: https://www.longdom.com/oncology

Cancer Treatment-2020 Report

We gratefully thank all our wonderful speakers, conference attendees, students, media partners, associations and exhibitors for making Cancer Treatment-2020 conference the best ever!

International Conference on Cancer-Treatment and Therapeutics, hosted by the Longdom Conference was held during November 23-24, 2020   New York, USA based on the theme “Future Advancement on Cancer Research

The conference was initiated with the honourable presence of the keynote forum. The list includes:

  1. Mohammad Hojouj, Department-of Oncology and Medical Radiology, Ukraine
  2. Nauman Arif, Khyber Medical University, Pakistan
  3. Ashok Srivastava, Chief Medical Officer of Clin Fomatrix, USA
  4. Miriam Al Guero Josa, President and founder of the Spanish and Latinamerica Integrative Oncology Society, Spain
  5. Geert C Mudde, Immunology Department, France

With the grand success of Cancer Treatment-2020, Longdom Conferences  is proud to announce the "International Conference on Clinical Oncology" to be held February 23-24, 2022 at Singapore city, Singapore.

For more details visit: https://www.longdom.com/oncology

Who can attend? 

  • Professors
  • Ph.D. Scholars and Graduates
  • Directors and CEO’s of Organizations
  • Deans and Head of Departments
  • Nanomaterial Societies and Associations
  • Business Delegates and Exhibitors

 

Mode of Participations:

  • Speaker
  • Delegate
  • Workshops
  • Poster
  • Symposiums
  • Exhibitors Booth and Stalls
  • Sponsorship
  • E-Video Presentation
  • E-poster presentation
  [email protected]
  [email protected]
  [email protected]
Speakers Interview